Fractures in Patients With Acute Calcium Pyrophosphate Crystal Arthritis Versus Matched Comparators in a Large Cohort Study
Arthritis & Rheumatology · 2024-06 · 76 (6) · 936-941
DOI: 10.1002/art.42798 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Arthritis & Rheumatology, online erschienen am 08.02.2024. Verfasst von Sara K Tedeschi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Brigham and Women's Hospital, Boston, Massachusetts. Hauptthemen laut MEDLINE: Chondrocalcinosis, Fractures, Bone. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIAMS NIH HHS, NIH.
Abstract (Originalsprache)
Objective
Calcium pyrophosphate deposition (CPPD) disease was associated with osteopenia in two cross‐sectional studies. We compared fracture risks in patients with acute calcium pyrophosphate (CPP) crystal arthritis versus matched comparators.
Methods
We performed a longitudinal cohort study using electronic health record data from a single large academic health system, with data from 1991 to 2023. Patients with one or more episodes of acute CPP crystal arthritis were matched to comparators on the index date (first documentation of “pseudogout” or synovial fluid CPP crystals or matched encounter) and first encounter in the health system. The primary outcome was first fracture at the humerus, wrist, hip, or pelvis. We excluded patients with fracture before the index date. Covariates included demographics, body mass index, smoking, comorbidities, health care use, glucocorticoids, and osteoporosis treatments. We estimated incidence rates and adjusted hazard ratios for fracture. Sensitivity analyses excluded patients prescribed glucocorticoids, patients prescribed osteoporosis treatments, or patients with rheumatoid arthritis and additionally adjusted for chronic kidney disease.
Results
We identified 1,148 patients with acute CPP crystal arthritis matched to 3,730 comparators, with a mean age of 73 years. Glucocorticoids and osteoporosis treatments were more frequent in the acute CPP crystal arthritis cohort. Fracture incidence rates were twice as high in the acute CPP crystal arthritis cohort (11.7 per 1,000 person‐years) versus comparators (5.5 per 1,000 person‐years). After multivariable adjustment, fracture relative risk was twice as high in the acute CPP crystal arthritis cohort (hazard ratio 1.8 [95% confidence interval 1.3–2.3]); results were similar in sensitivity analyses.
Conclusion
In this first published study of fractures and CPPD, fracture risk was nearly doubled in patients with acute CPP crystal arthritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Brigham and Women's Hospital, Boston, Massachusetts.
- Medical College of Wisconsin, Milwaukee, Wisconsin.
ORCID-Profile: Sara K Tedeschi, Ann Rosenthal
Förderung
- NIH HHS
- NIAMS NIH HHS
- NIH
Zitieren
APA
Tedeschi, S. K., Hayashi, K., Rosenthal, A., Gill, M., Marrugo, J., Fukui, S., Gravallese, E., & Solomon, D. H. (2024). Fractures in Patients With Acute Calcium Pyrophosphate Crystal Arthritis Versus Matched Comparators in a Large Cohort Study. Arthritis & Rheumatology, 76(6), 936-941. https://doi.org/10.1002/art.42798
Vancouver
Tedeschi SK, Hayashi K, Rosenthal A, Gill M, Marrugo J, Fukui S, et al. Fractures in Patients With Acute Calcium Pyrophosphate Crystal Arthritis Versus Matched Comparators in a Large Cohort Study. Arthritis & Rheumatology. 2024;76(6):936-941. doi:10.1002/art.42798
BibTeX
@article{Tedeschi2024,
author = {Tedeschi, Sara K and Hayashi, Keigo and Rosenthal, Ann and Gill, Muneet and Marrugo, Javier and Fukui, Sho and Gravallese, Ellen and Solomon, Daniel H},
title = {Fractures in Patients With Acute Calcium Pyrophosphate Crystal Arthritis Versus Matched Comparators in a Large Cohort Study},
journal = {Arthritis & Rheumatology},
year = {2024},
volume = {76},
number = {6},
pages = {936--941},
doi = {10.1002/art.42798}
}
EUVIMED